FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Treatments topics
Treatments
Gallium Nitride
Buffer Layer
Solubility
Phase Shift
Irradiation
Pharmaceutically Acceptable Salt
Magnetic Field
Synchronous
Transcranial Magnetic Stimulation
Transcranial
Guidelines
Lab Result
Transplant
Carbon Dioxide

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Treatments patents



      
           
This page is updated frequently with new Treatments-related patents. Subscribe to the Treatments RSS feed to automatically get the update: related Treatments RSS feeds.

Subscribe to updates on this page: Treatments RSS RSS

Date/App# patent app List of recent Treatments-related patents
04/17/14
20140108076
 Retail point seed treatment systems and methods patent thumbnailnew patent Retail point seed treatment systems and methods
An automated seed treatment system is adapted for on-site operation at a retail seed distributor. A sealed seed-treater vessel is configured to apply a plurality of chemical treatments to a batch of seed based on a seed treatment recipe.
04/17/14
20140108045
 Epoch of care-centric healthcare system patent thumbnailnew patent Epoch of care-centric healthcare system
A computer-based system and method improves the efficiency (quality and/or cost) of healthcare services provided to a patient by modeling an epoch of care (eoc) of the patient and by using the epoch of care model to assist in the provision of healthcare services to the patient, such as by generating predictions of healthcare outcomes for the patient and by making recommendations for actions to be taken in connection with the provision of healthcare services to the patient. An epoch of care of a patient may include all services (e.g., treatments, diagnoses, prognoses, tests, tasks, communications, education), products (e.g., medications, medical equipment, implants), and outcomes (e.g., readmissions, morbidities, patient satisfaction, symptoms) that are related to a particular medical condition or complaint of the patient over a period of time.
04/17/14
20140107776
 Prostheses for ocular drug delivery and other treatments for glaucoma, macular degeneration, and other eye disorders or diseases patent thumbnailnew patent Prostheses for ocular drug delivery and other treatments for glaucoma, macular degeneration, and other eye disorders or diseases
A scleral prosthesis includes an elongated body that is narrower in a middle and wider at opposing first and second ends. The body includes multiple first portions that form the first end of the body, where the first portions separated lengthwise along the body.
04/17/14
20140107222
 Treatments for social learning disorders patent thumbnailnew patent Treatments for social learning disorders
The use of pak1 inhibitors to treat social or learning disabilities is disclosed. In one embodiment patients exhibiting social or learning disabilities as well as abnormally low nf1 activity are administered pak inhibitors to treat the social or learning disabilities.
04/17/14
20140107102
 Ocular allergy treatments patent thumbnailnew patent Ocular allergy treatments
Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.. .
04/17/14
20140106412
 Screw compression process for the conversion of lignocellulosic suspensions containing a high proportion of dry material patent thumbnailnew patent Screw compression process for the conversion of lignocellulosic suspensions containing a high proportion of dry material
The invention describes a process for the conversion of aqueous suspensions of lignocellulosic solids comprising a solids content of between 1 and 20% of dry material, said process comprising a step a) for compression of said suspension so as to separate the liquid phase present in and between the solids from the compressed solid phase and a step b) for extraction of at least the liquid phase, said liquid phase then being homogenised by heat and/or chemical treatments and reinjected on to the compressed solid phase.. .
04/17/14
20140106096
 Packaging patent thumbnailnew patent Packaging
A packaging film including one or more layers of biaxially oriented polypropylene film and an antiblocking agent. The type and amount of antiblocking agent can be tailored such that the film does not visibly scratch an item in contact with the film during normal distribution and handling.
04/17/14
20140106005
 Compositions and methods of use of phorbol esters in the treatment of neoplasms patent thumbnailnew patent Compositions and methods of use of phorbol esters in the treatment of neoplasms
Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms, treatments, or sequelae of disease.
04/17/14
20140105978
 Silk microspheres for encapsulation and controlled release patent thumbnailnew patent Silk microspheres for encapsulation and controlled release
A method was developed to prepare silk fibroin microspheres using lipid vesicles as templates to efficiently load therapeutic agents in active form for controlled release. The lipids are subsequently removed through the use of a dehydration agent, such as methanol or sodium chloride, resulting in β-sheet structure dominant silk microsphere structures having about 2 μm in diameter.
04/17/14
20140105941
 Remineralizing and desensitizing compositions, treatments and methods of manufacture patent thumbnailnew patent Remineralizing and desensitizing compositions, treatments and methods of manufacture
Improved remineralizing and desensitizing compositions containing remineralizing ingredients in aqueous-free emulsions that, in the presence of saliva, form mucoadhesive gels substantive to tooth surfaces; wherein the gels are dissolved by saliva gradually releasing remineralizing ingredients onto tooth surfaces, treatments with these compositions and methods of manufacture.. .
04/17/14
20140105884
new patent Material and method for treating internal cavities
Disclosed herein are materials, means and methods for sustained release of therapeutic agents for topical treatments. In particular, disclosed are means and methods for topical treatment of diseases of internal body cavities by embedding therapeutic agents in a slowly degrading biocompatible mixture applied to affected tissue..
04/17/14
20140105824
new patent Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
Provided herein are diagnostic methods for identifying subjects susceptible to treatment with a hypoxia-activated agent, and related methods. Also provided herein are methods of monitoring treatments with anti-hyaluronan agents, and related methods..
04/10/14
20140100489
Method and apparatus for delivering low power optical treatments
An apparatus is disclosed that uses at least one low power optical radiation source in a suitable head which can be held over a treatment area for a substantial period of time or can be moved over the treatment area a number of times during each treatment. The apparatus, a hand held light emitting applicator (lea) or light emitting skin applicator (lesa), can be in the form of a brush or roller adapted to be moved over the patient's skin surface as radiation is applied to the skin.
04/10/14
20140099367
Use of spironolactone-based composition that exhibits an inhibitory action on t-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis
The present invention relates to the use of spironolactone for the preparation of a pharmaceutical composition intended for preventing and/or treating multiple sclerosis. Alternatively, the invention relates to the use of spironolactone directly in t-lymphocytes or dendritic cells obtained from a blood sample taken from a patient and then injected back into the circulation.
04/10/14
20140099298
Botulinum toxin treatments of depression
Methods for preventing or treating depression including a depression mediated by the thalamus. Depression, including a thalamically mediated depression, can be treated by peripheral administration of a botulinum toxin to or to the vicinity of a trigeminal sensory nerve, thereby preventing or treating the depression..
04/10/14
20140097144
Stable percarboxylic acid compositions and uses thereof
The present invention relates generally to stable percarboxylic acid compositions comprising, inter alia, at least two stabilizing agents, and various uses for water treatments, including water treatments in connection with oil- and gas-field operations. The present invention also relates to slick water compositions and gel based compositions that comprise stable percarboxylic acid compositions and the use thereof in oil- and gas-field operations..
04/03/14
20140094493
Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease
Their preparation and novel intermediates, compositions thereof and their use in the prevention or treatment of cardiac and cardiovascular disease and methods for the treatment thereof.. .
04/03/14
20140093900
Steroid profile in ovarian follicular fluid for diagnosis, prognosis and determining strategies for treatment
Concentrations of endogenous steroids in ovarian follicular fluid are used to develop steroid profiles which provide means for the diagnosis and prognosis of endocrine-related conditions and for identifying and developing appropriate treatments for related conditions, including the identification and development of suitable protocols for in vitro fertilization (ivf), treatment and predictive strategies for successful ivf outcomes and selected uses of oocytes for ivf or embryonic stem cell procedures.. .
04/03/14
20140093790
Nanofibrous electrocatalysts
A nanofibrous catalyst and method of manufacture. A precursor solution of a transition metal based material is formed into a plurality of interconnected nanofibers by electro-spinning the precursor solution with the nanofibers converted to a catalytically active material by a heat treatment.
04/03/14
20140093596
Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection
Extracts derived from plants of the tsuga genus having anti-inflammatory and antimicrobial properties are provided. The tsuga extracts are suitable for the treatment of inflammation, irritation and/or infection.
04/03/14
20140093565
A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof
The invention relates to a pharmaceutical composition comprising a hdac inhibitor, a pharmaceutically acceptable acid or a salt thereof or a mixture thereof and a steroid or a pharmaceutically acceptable salt thereof as well use of said pharmaceutical composition for the treatment of cancer as a pretreatment prior to other treatments. Said hdac inhibitor or steroid may alternatively be administrated separately prior to additional treatments..
04/03/14
20140093421
Chitosan-based hemostatic textile
A microfibrillar high molecular weight chitosan-based textile can be used as a hemostat. The chitosan has been treated in a nitrogen field by applying energy to ionize nitrogen in and around the chitosan textile.
04/03/14
20140090695
Solar roof panel system with edge and surface treatments
A roof-mounted solar power system for generating electrical power that includes a plurality of solar modules adapted for generating electrical power from sunlight, and with each of the plurality of solar modules having substantially the same size, aspect ratio and surface coloring. The plurality of solar modules are mounted on the deck of a roof to form a bank of solar modules having at least one irregular edge.
03/27/14
20140089003
Patient health record similarity measure
Computer-implemented methods for determining optimal treatments for a patient can include identifying successful treatments used in cohorts of persons considered similar to the patient. Tools implementing such methods can use biological sequence analysis techniques to identify practices best suited for the patient..
03/27/14
20140088990
Systems and methods for surgical and interventional planning, support, post-operative follow-up, and, functional recovery tracking
Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, a patient can be tracked throughout medical treatment including through initial onset of symptoms, diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment.
03/27/14
20140088552
Intravitreal injection device
The present disclosure provides a new and improved intravitreal injection device, which is capable of locating the injection site with precision and reproducibility, ensuring the smooth delivery of medications or other treatments, and reducing potential need contaminations. In various embodiments, the device comprises a head unit and a hollow stem extending orthogonally from a bottom of the head unit.
03/27/14
20140088199
Ophthalmic treatments
Aqueous compositions suitable for topical administration to the human or animal eye contain at least one water-soluble polymeric ophthalmic lubricant, such as hyaluronate, carbomer gel or hypromellose, together with a water-soluble analgesic. The analgesic may be an opiod, particularly an opioid having an affinity for 5-ht receptors, such as tramadol.
03/27/14
20140087403
Low-volume coagulation assay
Compositions and methods for measuring coagulation parameters using very small volumes of blood are provided. Advantageously, the methods described herein can be performed from a single drop of blood (about 20 μl) while generally leaving enough sample to perform other measurements, optionally in a multiplexed format.
03/27/14
20140086833
Non-invasive diagnostic agents and methods of diagnosing infectious disease
The present invention is directed to novel non-invasive diagnostic tools to diagnose numerous infectious disease states or conditions. The present invention represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these disease states.
03/27/14
20140086251
Ethernet differentiated services architecture
An edge node of a communication network and method to classify incoming ethernet traffic based on predetermined criteria. An ingress switch is configured to receive an incoming ethernet frame.
03/27/14
20140084910
Surface property inspection device and surface property inspection method
To provide a surface property inspection device and surface property inspection method with which the surface treatment condition of treated material such as steel subjected to such surface treatments as shot-peening treatment or heat treatment, nitriding, and the like can be non-destructively and precisely inspected, and which offers a high degree of general purpose application. A surface property inspection device 1 includes an ac power supply, an ac bridge circuit, and a judgment device, and the ac bridge circuit has a variable resistor with a variable split ratio γ, a benchmark detector, and an inspection detector.
03/27/14
20140083358
Seed treatment facilities, methods, and apparatus
A seed treatment system having a central computerized data store, a user interface, and network connections from the data store to a plurality of retail facilities and a plurality of agricultural produce suppliers. Each retail facility having a seed treatment system configured to uniformly treat batches of seeds with any of a variety of precisely measured chemical formulations.
03/20/14
20140081898
Medical care treatment decision support system
Exemplary embodiments of the present invention will assist patients with their investigation of, and decision making about, the treatments that are available to them using conjoint analysis methods that measure individual preferences for risk-associated treatment options, while maintaining an acceptable interview length. In exemplary embodiments, such individual preferences, known as “utilities” in economics literature, will be combined with evidence-based outcomes data regarding the probabilities of treatment outcomes; exemplary embodiments will use “decision analysis” and modified “conjoint analysis” methods, to dynamically generate for patients real-time individualized, evidence-based feedback, rankings and recommendations regarding medical treatment alternatives that are available to the patient based on the patient's medical condition and prognostic indicators..
03/20/14
20140081659
Systems and methods for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking
Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, a patient can be tracked throughout medical treatment including through initial onset of symptoms, diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment.
03/20/14
20140081109
Microdialysis sampling/delivery device
This present invention provides real-time in vivo sampling via ultra-small volume microdialysis of the intervertebral disc to assay single molecules of interest. The invention consists of three lumena, two that are capped with a membrane capable of sampling tissues via diffusion.
03/20/14
20140080905
Method of treating estrogen receptor (er) -positive breast cancers with selective androgen receptor modulator (sarms)
This invention relates to the treatment of androgen receptor-positive breast cancer in a subject, for example a female subject. Accordingly, this invention provides methods of: a) treating a subject suffering from breast cancer; b) treating a subject suffering from metastatic breast cancer; c) treating a subject suffering from refractory breast cancer; d) treating a subject suffering from ar-positive breast cancer; e) treating a subject suffering from ar-positive refractory breast cancer; f) treating a subject suffering from ar-positive metastatic breast cancer; g) treating a subject suffering from ar-positive and er-positive breast cancer; h) treating a subject suffering from triple negative breast cancer; i) treating a subject suffering from advanced breast cancer; j) treating a subject suffering from breast cancer that has failed serm (tamoxifen, toremifene), aromatase inhibitor, trastuzumab (herceptin, ado-trastuzumab emtansine), pertuzumab (perjeta), lapatinib, exemestane (aromasin), bevacizumab (avastin), and/or fulvestrant treatments; k) treating, preventing, suppressing or inhibiting metastasis in a subject suffering from breast cancer; l) prolonging survival of a subject with breast cancer, and/or m) prolonging the progression-free survival of a subject with breast cancer; comprising administering to the subject a therapeutically effective amount of a selective androgen receptor modulator (sarm) compound, comprising administering to the subject a therapeutically effective amount of a sarm compound of this invention..
03/20/14
20140080772
Treatments for melanoma
The present invention relates to mono- and combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include ro 31-8220, bafetinib, and cardiac glycosides..
03/20/14
20140080763
N-carboxyalkylauristatins and use thereof
The present application relates to new derivatives, substituted on the n terminus by a carboxyalkyl group, of monomethylauristatin e and monomethylauristatin f, to processes for preparing these derivatives, to the use of these derivatives for treating and/or preventing diseases, and to the use of these derivatives for producing medicaments for treating and/or preventing diseases, more particularly hyperproliferative and/or angiogenic disorders such as cancer disorders, for example. Such treatments may be applied as a monotherapy or else in combination with other medicaments or further therapeutic measures..
03/20/14
20140079804
Compositions and methods for treatment of infections
This invention relates to the field of topical treatments for infections such as nail infections, particularly fungal infections of the nail commonly referred to as onychomycosis. Particularly, the invention relates to novel compositions containing peroxide for the treatment of such nail infections and other infections..
03/20/14
20140079767
Cancer treatments and compositions for use thereof
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of cancer or other conditions. In some cases, the composition may include nitric oxide.
03/20/14
20140079686
Methods for treating baldness and promoting hair growth
The invention relates to methods of treating baldness, treating alopecia, promoting hair growth, and/or promoting hair follicle development and/or activation or stimulation on an area of the skin of a subject (for example, a human) by subjecting said area of the skin to integumental perturbation. Integumental perturbation can be used in combination with other treatments for promoting hair growth.
03/20/14
20140076600
Changing colors of materials
The described embodiments relate generally to cosmetic surfaces and associated treatments to alter a color of cosmetic surfaces. According to one embodiment, cosmetic ink configured to be applied to a cosmetic surface can include a suspension matrix configured to suspend a number of small particles in the suspension matrix.
03/13/14
20140074012
Composition, system and method for tissue augmentation
A composition for purposes of augmentation contains a plurality of substantially spherical, biocompatible semi-solid beads each having a diameter in the range of about 1 millimeter to 10 millimeters. The composition also includes a delivery solvent for sanitary lubrication of the beads.
03/13/14
20140073850
Pelvic floor treatments and related tools and implants
Described are implants, tools, and methods useful for treating pelvic conditions such as prolapse, by placing an implant to support pelvic tissue, the implants, tools, and methods involving one or more of adjusting engagements, specific implants and pieces of implants, placement of implants at locations within the pelvic region, and insertion, adjusting, and grommet management tools.. .
03/13/14
20140073680
Bladder cancer treatment and methods
Therapeutic compositions comprising an indoloquinone compound and various bladder cancer treatments and methods are disclosed. More specifically, the compositions comprise an indoloquinone compound and a formulation vehicle.
03/13/14
20140073502
Enhanced seed treatments using oils
A stabilized oil-in-water seed treatment formulation having superior handling characteristics.. .
03/13/14
20140072973
Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis
Disclosed herein are point mutations in the lmna gene that cause hgps. These mutations activate a cryptic splice site within the lmna gene, which leads to deletion of part of exon 11 and generation of a mutant lamin a protein product that is 50 amino acids shorter than the normal protein.
03/13/14
20140072571
Osteoporosis associated markers and methods of use
Disclosed are methods of identifying subjects with osteoporosis or osteopenia, subjects at risk for developing osteoporosis, osteopenia, and bone fractures, methods of evaluating the effectiveness of osteoporosis treatments in subjects with osteoporosis or osteopenia, and methods of selecting therapies for treating osteoporosis or osteopenia, using biomarkers.. .
03/13/14
20140071465
Techniques related to printing
Application of treatments for treating a colorant for printing an image is described herein. In an example, an amount of a treatment to be applied on a substrate portion is determined considering color calibration of a printing system for specific conditions of printing the image.
03/13/14
20140069870
Glycidol functionalized anion exchange stationary phases
Treatment of anion exchange materials containing hydroxyl containing moieties in the beta position relative to the quaternary center in the hydroxide form with glycidol substantially alters the selectivity of the anion exchange material. Furthermore, sequential treatments of first a hydroxide containing solution to put the anion exchange material in the hydroxide form followed by treatment with glycidol in an alternating sequence progressively changes selectivity in a predictable manner allowing facile manipulation of selectivity.
03/06/14
20140067408
Systems and methods for use in training medical treatments to healthcare professionals
A medical event information system includes at least one client computer, a memory area configured to store at least one property of an object, and a server system communicatively coupled to the client computer and the memory area. The memory area is configured to store data associated with a plurality of medical events, wherein each medical event resulted in a legal assertion being made by a patient following a surgical procedure.
03/06/14
20140066392
Combination treatments for melanoma
The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such therapies in include braf inhibitors such as plx 4720 and plx 4734 in combination with ro 31-8220, bafetinib or cardiac glycosides..
03/06/14
20140065571
Intraoral maxretractor
An intraoral retractor includes a main body plane with one curved end and is dented in the middle to avoid injure the frenum; and the other end is a handle bended 30 degree away from the plan of the body. The grasper is inserted within a patient's mouth to retract the lip and open the patient's mouth vertically, while the handle allows easy operation.
03/06/14
20140060831
Well treatment methods and systems
Methods, fluids, equipment and/or systems for treating a subterranean formation penetrated by a wellbore, which use less water, less energy, less equipment, have a smaller wellsite footprint, a reduced carbon dioxide emission, an improved distribution of proppant among a plurality of flow paths, an improved stimulation of reservoir fluid production, an improved risk management method, or the like, or any combination thereof, relative to comparable conventional treatment methods, fluids, equipment and/or systems such as, for example, hydraulic fracture treatments of subterranean formations using slickwater and/or high-viscosity treatment fluids.. .
03/06/14
20140060561
Aperture brush with engaging product insert
A brush for the hair and scalp which is able to disperse styling products, therapeutic, and medicated treatments from a coated insert when used with a hair dryer. The brush's handle having a lever which is able to progress and retract the aligning of cylindrical housing tubes encasing a product insert.
02/27/14
20140058683
Methods for assessing drug efficacy and response of a patient to therapy
Methods of identifying, monitoring and matching patients with appropriate treatments using a systemic mediator-associated physiologic test profile are provided. The methods of the present invention increase the likelihood of demonstrating clinical efficacy in clinical trial datasets..
02/27/14
20140056998
System and method for diagnosis and treatment of neuropsychiatric disorders
An assay for a gch1 allele and associated genotype for the screening, prediction, diagnosis, prognosis, treatment and treatment response of psychiatric, neuropsychiatric, and neurological disorders, such as schizophrenia, schizoaffective disorder and bipolar disorder, and for defining treatments of such disorders. The presence of a variant in the gch1 gene, alone or in conjunction with a measurement of low or altered biopterin, or altered bh4 system measures, is used to screen or diagnose subjects at risk for developing a psychiatric, neuropsychiatric, or neurological disorder.
02/27/14
20140056838
Recreational water with improved interaction with skin, hair and eyes
The feel of skin and hair and the manageability of hair exposed to recreational water is improved by the addition of select organic polymers, e.g., charged organic polymers such as cationic organic polymers containing multiple charges. In one embodiment, excellent results are achieved when the added organic polymer(s) include polymeric quaternary ammonium compounds such as poly-dadmac.
02/27/14
20140054038
Methods for completing subterranean wells
Well cement compositions comprise water, an inorganic cement and one or more fillers having a thermal expansion coefficient (cte) that is lower than about 3×10−6/° c. The presence of low-cte fillers may reduce cement-sheath shrinkage when the well temperature falls during stimulation treatments, cyclic steam injection or when the well temperature reaches equilibrium at the top of a long casing string..
02/27/14
20140054037
Methods for completing subterranean wells
Methods for cementing a subterranean well comprise installing a casing string into a borehole, wherein the casing string comprises a metal having a coefficient of thermal expansion (cte) lower than about 6×10−6/° c. A cement sheath is then placed between the exterior surface of the casing string and the formation wall.
02/20/14
20140052473
Method and system for coordinating healthcare and human services
Disclosed is a system and method for coordinating health care decisions between a participant in the health care system, the health care providers for the participant, the various subscribers, who may be the loved ones of the participant. By way of the system and method, the participant can take a more active role in making decisions regarding long term care.
02/20/14
20140052461
Readable indicia for insurance payment
Embodiments of the invention include systems, methods, and computer-program products for providing a readable indicia for insurance payments. The system may provide a readable indicia on a statement from a treatment provider, such as a medical treatment provider, where the user's insurance may have covered a portion of the treatment price.
02/20/14
20140052460
Readable indicia for medical office payment
Embodiments of the invention include systems, methods, and computer-program products for providing readable indicia for medical office payments. As such, a readable indicia may be presented at a point-of-transaction (pot) at a medical treatment providers for a user to select.
02/20/14
20140051773
Methods for predicting risk of developing hypertension
Methods using biomarkers, e.g., serum levels of st2, to predict risk of developing hypertension, as well as methods for treating subjects to reduce the risk of developing hypertension and methods for selecting and/or stratifying subjects for clinical trials of treatments to reduce the risk of hypertension.. .
02/20/14
20140051763
Methods of treating frontal temporal dementia (ftd) with comprising administering metal chelators to the upper one-third of the nasal cavity
The present invention comprises methods and pharmaceutical compositions for intranasal delivery of effective amounts of dfo directly to the cns, in particular the brain treatments that inhibit gsk3b in patients with psychiatric disorders including, but not limited to, bipolar disorder, depression, adhd and schizophrenia. In addition a treatment composition is disclosed which comprises dfo and in certain embodiments combines dfo with one or more of the psychotropic drug types, i.e., antipsychotics, mood stabilizers and antidepressants.
02/20/14
20140050914
Antireflective coatings with controllable porosity and refractive index properties using a combination of thermal or chemical treatments
In some embodiments, the current invention discloses methods and apparatuses for making coated articles including a two step treatment process of a coated layer. The first step of the heat treatment involves a thermally assisted curing of the coated layer at a low temperature, which can strengthen the bond formation in the coated layer, leading to better layer stability during the subsequent heat treatment.
02/20/14
20140050723
Cell-penetrating anti-dna antibodies and uses thereof inhibit dna repair
Antibodies that penetrate cell nuclei and inhibit dna repair or interfere with dna metabolism are provided for treatment of cancer (both directly and by sensitizing cancer cells to dna-damaging treatments) or inhibiting or preventing viral infection, proliferation or metabolism. The method involves treating cells with a composition containing cell-penetrating anti-dna antibodies or derivatives thereof, alone or in combination with treatment that induces dna damage such as dna-damaging chemotherapy or radiation.
02/20/14
20140050677
Personal care and medicinal products incorporating bound organosulfur groups
Personal care products useful for the maintenance of personal appearance and good health and minor treatments that do not require professional health care, as well as products that provide a combination of anti-oxidant, anti-inflammatory, antimicrobial, and anti-aging properties and are suitable for use without a prescription. The products utilize biomembrane permeable organosulfur compounds that can redox cycle between thiol, disulfide, and thiosulfinate forms in response to antioxidants and oxidants that are inside and outside of cells.
02/20/14
20140048184
Finish heat treatment method and finish heat treatment apparatus for iron powder
In a finish heat treatment method and finish heat treatment apparatus for an iron powder, a raw iron powder is placed on a continuous moving hearth and continuously charged into the apparatus. In the pretreatment zone, the raw iron powder is subjected to a pretreatment of heating the raw iron powder in an atmosphere of hydrogen gas and/or inert gas at 450 to 1100° c.
02/13/14
20140047570
Animal model of human cancer and methods of use
The subject invention pertains to a non-human animal model of human cancer, methods of producing a non-human animal model of human cancer, methods of using a non-human animal model to propagate human cancer cells, methods of using a non-human animal model to study cancer, methods of using a non-human animal model to screen potential treatments for a subject's cancer, methods of using a non-human animal model for treating cancer in a subject (providing personalized therapy), methods of using a non-human animal model for identifying a biomarker of cancer treatment; and methods of using a non-human animal model for selecting cancer patients for a clinical trial.. .


Popular terms: [SEARCH]

Treatments topics: Treatments, Gallium Nitride, Buffer Layer, Solubility, Phase Shift, Irradiation, Pharmaceutically Acceptable Salt, Magnetic Field, Synchronous, Transcranial Magnetic Stimulation, Transcranial, Guidelines, Lab Result, Transplant, Carbon Dioxide

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Treatments for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Treatments with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.5328

3269

8 - 0 - 71